Actively Recruiting
Introducing PartoMa Approach to Ethiopia for Improving Intrapartum Care and Maternal Survival: The Case of the Ethiopian Obstetric Surveillance System (PartoMa-Ethiopia)
Led by Haramaya Unversity · Updated on 2024-02-22
500
Participants Needed
2
Research Sites
104 weeks
Total Duration
On this page
Sponsors
H
Haramaya Unversity
Lead Sponsor
U
University of Copenhagen
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying the PartoMa approach, which includes locally agreed and achievable intrapartum care guidelines and a continuous in-house training program, to improve decision making during labor in Eastern Ethiopia. This study aims to introduce this approach along with continuous fetal heart rate monitoring using the MOYO device to reduce perinatal mortality and improve outcomes for mothers and newborns at two busy hospitals. The study is organized in four phases: baseline assessment, co-creation of context-specific intrapartum care guidelines, implementation of PartoMa seminars and fetal heart rate monitoring, and post-intervention evaluation. The PartoMa seminars and low dose high frequency trainings are introduced after adapting guidelines from Tanzania to fit the local setting. Health providers will use continuous fetal heart rate monitoring with the MOYO device to support decision making during labor. Participants include laboring women delivering at the study sites and health care providers. Women and their newborns will be followed until discharge. Researchers will collect data through interviews, observations, and record reviews to assess fetal heart rate monitoring practices, guideline compliance, and pregnancy outcomes. Key outcomes include stillbirth, birth asphyxia, maternal death, cesarean sections, and quality of intrapartum care. The study runs from June 2023 to May 2025 with ongoing monitoring and evaluation throughout.
CONDITIONS
Brief Title
Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women in labor delivering at the study sites during July - September 2023 and July - September 2025
- Birth attendants working in the obstetrics and gynecology departments during the baseline and intervention periods, July - September 2023 and July - September 2025
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Screening and enrollment visit
Duration - 3 months
Participants experience a baseline assessment of current intrapartum care practices, including interviews, record reviews, and observations over three months.
Ongoing observations and assessments during the baseline period
Duration - 3 months
Participants and local birth attendants collaborate to adapt intrapartum care guidelines specific to the hospital context over three months.
Meetings and guideline development sessions
Duration - 12 months
Participants receive PartoMa seminars, low-dose high-frequency training, and supportive supervision to improve intrapartum care.
PartoMa seminars and training sessions during the intervention period
Duration - 6 months
Participants undergo evaluation of the impact and sustainability of the PartoMa intervention using similar tools as baseline.
Data collection and assessments similar to baseline
Trial Site Locations
Total: 2 locations
1
Haramaya Hospital
Harar, Oromiya, Ethiopia
Actively Recruiting
2
Hiwot Fana University Hospital
Harar, Ethiopia
Not Yet Recruiting
Research Team
A
Abera Tura, PhD
H
Habtamu Bekele, MSc
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here